Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avid Bioservices, Inc. 10.50% Series E Convertible Preferred

25.06
+0.0000
Volume:- -
Turnover:- -
Market Cap:1.55B
PE:161.73
High:25.06
Open:25.06
Low:25.06
Close:25.06
Loading ...

Avid Bioservices Launches New Company Website Designed to Boost Company Brand Awareness and Enhance the Visitor Experience

GlobeNewswire
·
10 Feb

Avid Bioservices Acquired by GHO and Ampersand Capital

TIPRANKS
·
06 Feb

Avid Bioservices, Inc. Provides Notice of Fundamental Change and Make-Whole Fundamental Change to Holders of its Convertible Notes in Connection with Completed Merger

GlobeNewswire
·
05 Feb

GHO Capital, Ampersand Capital announce closing of Avid Bioservices acquisition

TIPRANKS
·
05 Feb

Avid Bioservices poised for significant growth with new partners GHO Capital and Ampersand Capital Partners

GlobeNewswire
·
05 Feb

Avid Bioservices’ stockholders approve transaction with GHO and Ampersand

TIPRANKS
·
31 Jan

Avid Bioservices (CDMO) Started a Sale Process

Insider Monkey
·
22 Jan

Avid Bioservices says ISS, Glass Lewis recommend vote ‘FOR’ transaction

TIPRANKS
·
21 Jan

RBC Capital Sticks to Its Hold Rating for Avid Bioservices (CDMO)

TIPRANKS
·
10 Jan

Press Release: Avid Bioservices Files Investor Presentation Highlighting Value Maximizing Transaction with GHO and Ampersand

Dow Jones
·
09 Jan

Avid Bioservices' Waiting Period for Acquisition by GHO, Ampersand Expires

MT Newswires Live
·
30 Dec 2024

Avid Bioservices announces expiration of HSR waiting period for acquisition

TIPRANKS
·
30 Dec 2024

Press Release: Avid Bioservices Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by GHO and Ampersand

Dow Jones
·
30 Dec 2024

BRIEF-Avid Bioservices Recommends Stockholders Vote For Value Maximizing Transaction

Reuters
·
19 Dec 2024

Avid Bioservices Recommends Stockholders Vote FOR Value Maximizing Transaction

GlobeNewswire
·
19 Dec 2024

Avid Bioservices Reports Revenue Growth Amid Acquisition Plans

TIPRANKS
·
12 Dec 2024

Avid Bioservices: Fiscal Q2 Earnings Snapshot

Associated Press Finance
·
11 Dec 2024

Avid Bioservices Q2 EPS $(0.27) Misses $(0.12) Estimate, Sales $33.50M Miss $33.80M Estimate

Benzinga
·
11 Dec 2024

Avid Bioservices reports Q2 EPS (27c), consensus (10c)

TIPRANKS
·
11 Dec 2024

Press Release: Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2024

Dow Jones
·
11 Dec 2024